Donate to our Appeal for Prostate Cancer research

Donate to our Appeal for Prostate Cancer research

We have the opportunity to make a significant impact on the lives of people living with and at risk of developing prostate cancer. Please consider making a gift to support this vital research today.

At Menzies, we are researching the genetics of prostate cancer to advance screening, treatment and outcomes.

Click here to donate to the appeal.

In Australia, prostate cancer is the most commonly diagnosed cancer in men. In 2018, it is estimated that over 17,500 new cases of prostate cancer will be diagnosed. In Tasmania, around 500 men are diagnosed with prostate cancer and around 100 men will die per year from prostate cancer related complications.

The detection and treatment of prostate cancer can be complex in terms of identifying men at risk, deciding who needs to be treated and determining which treatment will work best for individuals. Current methods are problematic as they are based on a “one size fits all” policy but we know, for example, that not all cancers are detected with the commonly used PSA (Prostate-Specific Antigen) test and not all men respond the same way to the same treatment.

At Menzies a team led by Dr Liesel FitzGerald (pictured) is using genetics to address these problems through Tasmanian family and population-based studies. With our rich genetic resources, we have the opportunity to make a significant impact on the lives of people living with and at risk of developing prostate cancer. Please consider making a gift to support this vital research today.